Description
Dual GLP-1/GIP receptor agonist studied for appetite and glucose regulation specifically for significant appetite suppression, reduced cravings, improved blood sugar control, and cardiometabolic effects. FDA-approved only as specific branded products; compounded versions are not FDA-approved.
